This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yahi, N. Articles by Fantini, J. Search for Related Content PubMed PubMed Citation Articles by Yahi, N. Articles by Fantini, J.

 Previous Article  |  Next Article 

J. Virol., 01 1995, 320-325, Vol 69, No. 1
Copyright © 1995, American Society for Microbiology

Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4- negative mucosal epithelial cell line

N Yahi, JM Sabatier, S Baghdiguian, F Gonzalez-Scarano and J Fantini
CNRS URA 1455, Laboratoire de Biochimie, Faculte de Medecine Nord, Marseille, France.

The glycosphingolipid galactosylceramide (GalCer), which binds gp120 with high affinity and specificity, is a potential alternative receptor for human immunodeficiency virus type 1 (HIV-1) in some CD4-negative neural and epithelial human cells, including the human colonic epithelial cell line HT-29. In the present study, we demonstrate that synthetic multibranched peptides derived from the consensus sequence of the HIV-1 V3 loop block HIV-1 infection in HT-29 cells. The most active peptide was an eight-branched multimer of the motif Gly-Pro-Gly-Arg-Ala- Phe which at a concentration of 1.8 microM induced a 50% inhibition of HIV-1 infection in competition experiments. This peptide was not toxic to HT-29 cells, and preincubation with HIV-1 did not affect viral infectivity, indicating that the antiviral activity was not due to a nonspecific virucidal effect. Using a high-performance thin-layer chromatography binding assay, we found that multibranched V3 peptides recognized GalCer and inhibited binding of recombinant gp120 to the glycosphingolipid. In addition, these peptides abolished the binding of an anti-GalCer monoclonal antibody to GalCer on the surface of live HT- 29 cells. These data provide additional evidence that the V3 loop is involved in the binding of gp120 to the GalCer receptor and show that multibranched V3 peptides are potent inhibitors of the GalCer-dependent pathway of HIV-1 infection in CD4-negative mucosal epithelial cells.

This article has been cited by other articles:

• Liu, X., Zha, J., Chen, H., Nishitani, J., Camargo, P., Cole, S. W., Zack, J. A. (2003). Human Immunodeficiency Virus Type 1 Infection and Replication in Normal Human Oral Keratinocytes. J. Virol. 77: 3470-3476 [Abstract] [Full Text]  
• Maresca, M., Mahfoud, R., Garmy, N., Fantini, J. (2002). The Mycotoxin Deoxynivalenol Affects Nutrient Absorption in Human Intestinal Epithelial Cells. J. Nutr. 132: 2723-2731 [Abstract] [Full Text]  
• Mahfoud, R., Garmy, N., Maresca, M., Yahi, N., Puigserver, A., Fantini, J. (2002). Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins. J. Biol. Chem. 277: 11292-11296 [Abstract] [Full Text]  
• El Messaoudi, K., Thiry, L. F., Liesnard, C., Van Tieghem, N., Bollen, A., Moguilevsky, N. (2000). A Human Milk Factor Susceptible to Cathepsin D Inhibitors Enhances Human Immunodeficiency Virus Type 1 Infectivity and Allows Virus Entry into a Mammary Epithelial Cell Line. J. Virol. 74: 1004-1007 [Abstract] [Full Text]  
• Hammache, D., Pieroni, G., Yahi, N., Delezay, O., Koch, N., Lafont, H., Tamalet, C., Fantini, J. (1998). Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3. J. Biol. Chem. 273: 7967-7971 [Abstract] [Full Text]  
• Fantini, J., Hammache, D., Delezay, O., Yahi, N., Andre-Barres, C., Rico-Lattes, I., Lattes, A. (1997). Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 gp120 and Inhibit HIV-1-induced Fusion and Entry. J. Biol. Chem. 272: 7245-7252 [Abstract] [Full Text]